Diagnostic Utility and Comparative Immunohistochemical Analysis of MITF-1 and SOX10 to Distinguish Melanoma In Situ and Actinic Keratosis: A Clinicopathological and Immunohistochemical Study of 70 Cases

被引:33
作者
Buonaccorsi, J. Noelle [1 ]
Prieto, Victor G. [2 ]
Torres-Cabala, Carlos [2 ]
Suster, Saul [1 ]
Plaza, Jose A. [1 ]
机构
[1] Med Coll Wisconsin, Dept Pathol, Sect Dermatopathol, Milwaukee, WI 53226 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Sect Dermatopathol, Houston, TX 77030 USA
关键词
MIFT-1; immunohistochemistry melanoma in situ; SOX10; MICROPHTHALMIA TRANSCRIPTION FACTOR; SUN-DAMAGED SKIN; FACTOR EXPRESSION; SOLAR LENTIGO; MARKER; TUMORS; DISTINCTION;
D O I
10.1097/DAD.0b013e318291485c
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100227 [皮肤病学];
摘要
The histologic assessment of intraepidermal melanocytic proliferations involving sun-damaged skin may be challenging in scant biopsy material. Melanoma in situ may occasionally be confused with intraepidermal melanocytic hyperplasia on sun-damaged skin; thus, dermatopathologists may use immunohistochemical studies to help distinguish these entities. Historically, melanoma antigen recognized by T-cells 1 (MART-1) has been regarded as a valuable stain to confirm intraepidermal melanocytes; however, MART-1 may overestimate the number of melanocytes because it labels the melanoma dendrites and might also label pigmented keratinocytes, including structures mimicking junctional melanocytic nests in the setting of a lichenoid infiltrate. A total of 70 cases were retrospectively chosen, including 50 cases of melanoma in situ and 20 cases of actinic keratoses. SOX10 and microphthalmia transcription factor 1 (MITF-1) were performed in all cases. In all cases, the number of cells within epidermis that were identified as melanocytes by immunohistochemistry was compared with the number of melanocytes observed by morphology on hematoxylin and eosin sections. All cases of melanoma in situ showed expression of SOX10; however, the proportion of atypical melanocytes showing strong nuclear positivity was variable and did not approach that seen in MITF-1. There was no expression of either MITF-1 or SOX10 in adjacent pigmented keratinocytes in the cases of actinic keratoses. Both MITF-1 and SOX10 can be used to differentiate melanoma in situ from actinic keratosis with melanocytic hyperplasia; however, MITF-1 exhibits slight superior sensitivity and seems to be a more effective immunostain than SOX10 for the identification and quantification of melanocytes in the setting of melanoma in situ, especially in cases where there is limited tissue.
引用
收藏
页码:124 / 130
页数:7
相关论文
共 18 条
[1]
SOX10 expression in superficial spreading and nodular malignant melanomas [J].
Agnarsdottir, Margret ;
Sooman, Linda ;
Bolander, Asa ;
Stromberg, Sara ;
Rexhepaj, Elton ;
Bergqvist, Michael ;
Ponten, Fredrik ;
Gallagher, William ;
Lennartsson, Johan ;
Ekman, Simon ;
Uhlen, Mathias ;
Hedstrand, Hakan .
MELANOMA RESEARCH, 2010, 20 (06) :468-478
[2]
Melan-A-Positive "Pseudomelanocytic Nests": A Pitfall in the Histopathologic and Immunohistochemical Diagnosis of Pigmented Lesions on Sun-Damaged Skin [J].
Beltraminelli, Helmut ;
Shabrawi-Caelen, Laila El ;
Kerl, Helmut ;
Cerroni, Lorenzo .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2009, 31 (03) :305-308
[3]
Distinction of Melanoma In Situ From Solar Lentigo on Sun-Damaged Skin Using Morphometrics and MITF Immunohistochemistry [J].
Black, Will H. ;
Thareja, Sumeet K. ;
Blake, Brett P. ;
Chen, Ren ;
Cherpelis, Basil S. ;
Glass, Lewis Frank .
AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2011, 33 (06) :573-578
[4]
The use and application of special techniques in assessing melanocytic tumours [J].
Busam, KJ .
PATHOLOGY, 2004, 36 (05) :462-469
[5]
Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma [J].
Busam, KJ ;
Iversen, K ;
Coplan, KC ;
Jungbluth, AA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (02) :197-204
[6]
El Shabrawi-Caelen L, 2004, AM J DERMATOPATH, V26, P364
[7]
An immunohistochemical comparison between MiTF and MART-1 with Azure blue counterstaining in the setting of solar lentigo and melanoma in situ [J].
Hillesheim, Paul B. ;
Slone, Steve ;
Kelley, Denise ;
Malone, Janine ;
Bahrami, Soon .
JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (07) :565-569
[8]
Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ [J].
Kim, Jinah ;
Taube, Janis M. ;
McCalmont, Timothy H. ;
Glusac, Earl J. .
JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (10) :775-779
[9]
Microphthalmia transcription factor - A sensitive and specific melanocyte marker for melanoma diagnosis [J].
King, R ;
Weilbaecher, KN ;
McGill, G ;
Cooley, E ;
Mihm, M ;
Fisher, DE .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (03) :731-738
[10]
Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors [J].
King, R ;
Googe, PB ;
Weilbaecher, KN ;
Mihm, MC ;
Fisher, DE .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (01) :51-57